Olivia Gull, Analyst on the Governance and Responsible Investment Team, examines how pharmaceutical companies are addressing the issue of inequitable access to medicine, specifically in low and middle-income countries.
John Bennett and Tom O’Hara, European equities portfolio managers, explain why investing in so-called high ESG risk companies can prove to be beneficial as an active manager.
Olivia Gull, Analyst on the Governance and Responsible Investment Team, examines how pharmaceutical companies are addressing the issue of inequitable access to medicine, specifically in low and middle-income countries.
In our latest podcast episode, Heidi Hanna shares strategies for controlling stress – and taking advantage of it – during this time of uncertainty.
John Bennett and Tom O’Hara, European equities portfolio managers, explain why investing in so-called high ESG risk companies can prove to be beneficial as an active manager.
Jamie Ross, Fund Manager for Henderson EuroTrust, delivers his monthly commentary on how the Trust performed in April, portfolio activity and his thoughts on wider economic and political developments.
Job Curtis, Fund Manager for The City of London Investment Trust, provides his monthly commentary on how the Trust performed in April, which sectors and stocks contributed to its performance and his thoughts on the wider economic outlook.
How pharmaceutical companies are addressing the issue of inequitable access to medicine.
Head of U.S. Fixed Income Greg Wilensky shares his thoughts on today’s employment report and why it doesn’t change our long-term outlook.
Though risks remain, we expect an accelerating and broadening economic recovery in 2021.